The Natural Coagulation Inhibitors, Inflammation, and Thrombotic Risk in Sickle Cell Patients in Cameroon: An Analytical Cross‐Sectional Study
Romaric De Manfouo Tuono, Josué Louokdom Simo, Paule Rita Ngamgwe Tchouanmo, Ingrid Worti Sulem Yong, Maryline Seuko Njopwouo, Claude Tagny Tayou, Vittorio Emanuele Muccio · 2026
Read The Natural Coagulation Inhibitors, Inflammation, and Thrombotic Risk in Sickle Cell Patients in Cameroon: An Analytical Cross‐Sectional Study by Romaric De Manfouo Tuono, Josué Louokdom Simo, Paule Rita Ngamgwe Tchouanmo, Ingrid Worti Sulem Yong, Maryline Seuko Njopwouo, Claude Tagny Tayou, Vittorio Emanuele Muccio (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13181923.txt.
Description
Romaric De Manfouo Tuono and co-authors studied clot risk in people with sickle cell disease in Cameroon, in a 2026 study. Sickle cell disease warps red blood cells and inflames vessel walls, both of which favor clots. The body also keeps natural brakes on clotting, and the team asked how those brakes link with inflammation in these patients.
Over one year at Bafoussam Regional Hospital, they drew blood from patients with the full form of the disease. Tests measured three natural brake proteins, along with blood counts and signs of inflammation. Their aim was to judge each patient's clot risk from these measures, so care can target those most at risk.
Catalog record
| CREATOR | Romaric De Manfouo Tuono, Josué Louokdom Simo, Paule Rita Ngamgwe Tchouanmo, Ingrid Worti Sulem Yong, Maryline Seuko Njopwouo, Claude Tagny Tayou, Vittorio Emanuele Muccio |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |